Factor Xa inhibitor - Bio-Technology General

Drug Profile

Factor Xa inhibitor - Bio-Technology General

Alternative Names: Factorex

Latest Information Update: 09 Oct 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator American Red Cross; Yissum Research Development Company
  • Developer Nonindustrial source; Savient Pharmaceuticals
  • Class
  • Mechanism of Action Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial occlusive disorders; Deep vein thrombosis; Thrombosis

Most Recent Events

  • 28 Dec 2000 This product is available for licensing (http://www.btgc.com)
  • 05 May 2000 Predicted peak sales have been added
  • 28 Mar 2000 A preclinical study has been added to the Thromboses pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top